In an adult female patient with early‑stage breast cancer undergoing breast‑conserving surgery, is the false‑negative margin rate higher with indocyanine green‑guided lumpectomy compared with intra‑operative frozen‑section analysis?

ICG-Guided Lumpectomy vs Frozen Section: False Negative Margin Rates

Based on available evidence, ICG fluorescence-guided lumpectomy demonstrates a comparable false-negative rate to frozen section analysis, with ICG achieving 81.82% sensitivity versus frozen section's 81.82% sensitivity, though ICG shows lower specificity (75.82% vs 94.83%). 1

Direct Comparison Data

The most relevant study directly comparing these modalities found:

• ICG fluorescence sensitivity: 81.82% (meaning ~18% false-negative rate)
• Frozen section sensitivity: 81.82% (meaning ~18% false-negative rate)
• Critical difference: ICG specificity was only 75.82% versus frozen section's 94.83%, indicating ICG produces more false-positives rather than false-negatives 1

Dose-Dependent Performance

ICG performance varies significantly by dosing:

• At 0.5 mg/kg: Sensitivity 66.67%, Specificity 93.33%
• At 1.0 mg/kg: Sensitivity 87.5%, Specificity 74.42%

Higher doses improve sensitivity (reduce false-negatives) but worsen specificity (increase false-positives) 1

Clinical Context from Guidelines

The SSO-ASTRO guidelines establish that "no ink on tumor" is the standard for adequate margins in invasive breast cancer 2. Positive margins increase local recurrence risk 2-fold or greater 2. This makes false-negative margin assessment particularly concerning, as it leaves patients with inadequate excision.

Frozen Section Performance Benchmark

Frozen section analysis demonstrates:

• Sensitivity: 92.5% (7.5% false-negative rate)
• Specificity: 99.8%
• Accuracy: 99.63% 3

Another study reported 84% accuracy per-case and 96% per-slide, with false-negatives affecting 19.6% of patients, particularly in DCIS cases 4

ICG Fluorescence Limitations

Critical caveat: ICG fluorescence achieved only 87% identification rate in one study (13/15 patients) 5, and another study found abnormal ICG fluorescence in only 11.6% of patients (5/43), including 3 with residual infiltrating carcinoma 6. This suggests ICG may miss positive margins entirely in some cases.

Technical Considerations

• ICG must be used within 6 hours of reconstitution 7
• Optimal timing remains unclear—studies use both intraoperative (0.125-0.25 mg/kg) and preoperative (0.5-2 mg/kg, 24h prior) administration 8
• No standardized protocol exists for ICG margin assessment

Practical Algorithm

For margin assessment during breast-conserving surgery:

1. Primary method: Frozen section analysis remains superior with ~92.5% sensitivity and 99.8% specificity 3

2. ICG as adjunct only: Use ICG fluorescence (1.0 mg/kg dose for optimal sensitivity) as a supplementary tool to guide frozen section sampling, not as replacement 1

3. Expect false-negatives with either method: Both techniques miss positive margins in approximately 8-19% of cases

4. DCIS caveat: Frozen section has particular difficulty with DCIS (p < 0.001), where false-negatives are more frequent 4. ICG performance in pure DCIS is not well-established.

Bottom Line

The false-negative rate is not substantially higher with ICG compared to frozen section (both ~18%), but ICG's lower specificity and lack of standardization make it unsuitable as a standalone margin assessment tool. Frozen section remains the gold standard, with ICG serving as a potential adjunct for real-time surgical guidance rather than definitive margin determination 1, 3.